Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics

    Nimodipine, an L-type cerebroselective calcium channel antagonist, is the only drug approved by the US Food and Drug Administration for the neuroprotection of patients with aneurysmal subarachnoid hemorrhage (...

    Adriana Vázquez-Medina, Marion T. Turnbull in The Pharmacogenomics Journal (2024)

  2. Article

    Open Access

    Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease

    Despite substantial progress, causal variants are identified only for a minority of familial Parkinson’s disease (PD) cases, leaving high-risk pathogenic variants unidentified1,2. To identify such variants, we un...

    Paul J. Hop, Dongbing Lai, Pamela J. Keagle, Desiree M. Baron in Nature Genetics (2024)

  3. Article

    Open Access

    Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction

    Restless legs syndrome (RLS) affects up to 10% of older adults. Their healthcare is impeded by delayed diagnosis and insufficient treatment. To advance disease prediction and find new entry points for therapy,...

    Barbara Schormair, Chen Zhao, Steven Bell, Maria Didriksen in Nature Genetics (2024)

  4. No Access

    Article

    Role of GBA variants in Lewy body disease neuropathology

    Rare and common GBA variants are risk factors for both Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). However, the degree to which GBA variants are associated with neuropathological features in Lew...

    Ronald L. Walton, Shunsuke Koga, Alexandra I. Beasley in Acta Neuropathologica (2024)

  5. No Access

    Article

    Cancer in pathologically confirmed multiple system atrophy

    The aim of this study was to assess whether cancer occurs with increased frequency in multiple system atrophy (MSA). The pathological hallmark of MSA is glial cytoplasmic inclusions containing aggregated α-syn...

    William P. Cheshire, Shunsuke Koga, Philip W. Tipton in Clinical Autonomic Research (2023)

  6. Article

    Open Access

    Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies

    Shunsuke Koga, Aya Murakami in Acta Neuropathologica Communications (2023)

  7. Article

    Open Access

    Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies

    Frontotemporal lobar degeneration (FTLD) is a group of disorders characterized by degeneration of the frontal and temporal lobes, leading to progressive decline in language, behavior, and motor function. FTLD ...

    Shunsuke Koga, Aya Murakami in Acta Neuropathologica Communications (2023)

  8. Article

    Open Access

    Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration

    Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are distinct clinicopathological subtypes of frontotemporal lobar degeneration. They both have atypical parkinsonism, and they usually h...

    Shunsuke Koga, Michael A. Metrick II in Acta Neuropathologica Communications (2023)

  9. Article

    Open Access

    Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures

    Dementia with Lewy bodies (DLB) is clinically diagnosed when patients develop dementia less than a year after parkinsonism onset. Age is the primary risk factor for DLB and mitochondrial health influences agei...

    Rebecca R. Valentino, Chloe Ramnarine in Acta Neuropathologica Communications (2022)

  10. Article

    Open Access

    APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology

    Approximately half of Alzheimer’s disease (AD) brains have concomitant Lewy pathology at autopsy, suggesting that α-synuclein (α-SYN) aggregation is a regulated event in the pathogenesis of AD. Genome-wide ass...

    Yunjung **, Fuyao Li, Berkiye Sonoustoun, Naveen Chandra Kondru in Acta Neuropathologica (2022)

  11. No Access

    Article

    Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease

    Tau deposition is one of two hallmark features of biologically defined Alzheimer’s disease (AD) and is more closely related to cognitive decline than amyloidosis. Further, not all amyloid-positive individuals ...

    Vijay K. Ramanan, Michael G. Heckman, Timothy G. Lesnick in Acta Neuropathologica (2022)

  12. No Access

    Article

    PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson’s disease in Ireland

    Variants in PARKIN, PINK1, and DJ1 are associated with early-onset Parkinson’ disease (EOPD, age-at-onset < 45). We previously reported a single PINK1 and a single DJ1 heterozygous variant carrier.

    Diana A. Olszewska, Allan McCarthy in Irish Journal of Medical Science (1971 -) (2022)

  13. No Access

    Article

    Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death

    The dual specificity protein phosphatases (Dusps) control dephosphorylation of mitogen-activated protein kinases (MAPKs) as well as other substrates. Here, we report that Dusp26, which is highly expressed in n...

    Binnur Eroglu, **ongjie **, Sadiki Deane in Cellular and Molecular Life Sciences (2022)

  14. Article

    Open Access

    Neuropathology and molecular diagnosis of Synucleinopathies

    Synucleinopathies are clinically and pathologically heterogeneous disorders characterized by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies, Lewy neurites, neuronal cytopl...

    Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, Owen A. Ross in Molecular Neurodegeneration (2021)

  15. Article

    Open Access

    A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech

    Progressive apraxia of speech is a neurodegenerative syndrome affecting spoken communication. Molecular pathology, biochemistry, genetics, and longitudinal imaging were investigated in 32 autopsy-confirmed pat...

    Keith A. Josephs, Joseph R. Duffy, Heather M. Clark in Nature Communications (2021)

  16. Article

    Open Access

    Latent trait modeling of tau neuropathology in progressive supranuclear palsy

    Progressive supranuclear palsy (PSP) is the second most common neurodegenerative Parkinsonian disorder after Parkinson’s disease, and is characterized as a primary tauopathy. Leveraging the considerable clinic...

    Naomi Kouri, Melissa E. Murray, Joseph S. Reddy, Daniel J. Serie in Acta Neuropathologica (2021)

  17. Article

    Open Access

    Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease

    Selective vulnerability of different brain regions is seen in many neurodegenerative disorders. The hippocampus and cortex are selectively vulnerable in Alzheimer’s disease (AD), however the degree of involvem...

    Angela M. Crist, Kelly M. Hinkle, Xue Wang, Christina M. Moloney in Nature Communications (2021)

  18. Article

    Open Access

    Co** with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology

    Although abnormal accumulation of amyloid in the brain is an early biomarker of Alzheimer’s disease (AD), wide variation in cognitive trajectories during life can be seen in the setting of brain amyloidosis, r...

    Vijay K. Ramanan, Timothy G. Lesnick in Acta Neuropathologica Communications (2021)

  19. No Access

    Article

    Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

    The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed whole-genome sequencing in large cohorts of LBD cases and neurologically healthy controls to study the genetic architect...

    Ruth Chia, Marya S. Sabir, Sara Bandres-Ciga, Sara Saez-Atienzar in Nature Genetics (2021)

  20. No Access

    Article

    Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy

    Investigate single nucleotide variants and short tandem repeats in 39 genes related to spinocerebellar ataxia in clinical and pathologically defined cohorts of multiple system atrophy.

    Anna I. Wernick, Ronald L. Walton, Alexandra I. Soto-Beasley in Clinical Autonomic Research (2021)

previous disabled Page of 4